CANAG DIAGNOSTICS AB has a total of 35 patent applications. Its first patent ever was published in 1999. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Brazil. Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are RES ASS FOR BIOTECHNOLOGY, CLONATEC SA and UNIV WALES.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | Australia | 5 | |
#3 | Brazil | 4 | |
#4 | Canada | 4 | |
#5 | EPO (European Patent Office) | 4 | |
#6 | Sweden | 4 | |
#7 | Hong Kong | 2 | |
#8 | Mexico | 2 | |
#9 | United States | 2 | |
#10 | China | 1 | |
#11 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Pharmaceuticals | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Analysing materials | |
#3 | Microorganisms | |
#4 | Therapeutic chemical compounds | |
#5 | Measuring microorganism processes | |
#6 | Unspecified technologies | |
#7 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Nilsson Olle | 15 |
#2 | Roejer Eva | 9 |
#3 | Olle Nilsson | 5 |
#4 | Fermer Christian | 5 |
#5 | Kubista Mikael | 5 |
#6 | Stalberg Anders | 3 |
#7 | Aman Pierre | 3 |
#8 | Rojer Eva | 3 |
#9 | Aaman Pierre | 2 |
#10 | Staalberg Anders | 2 |
Publication | Filing date | Title |
---|---|---|
US2008057520A1 | Immunoassays for specific determination of scca isoforms | |
WO2005123773A1 | Method for site-directed immunisation | |
CN1684981A | Immunoassays for specific determination of SCCA isoforms | |
AU2002309423B2 | Method to measure gene expression ratio of key genes | |
CA2440028A1 | Rearranged squamous cell carcinoma antigen genes ii | |
SE0101999D0 | Determining efficiency of a polymerase chain reaction (PCR), useful for clinical diagnosis, comprises estimating the efficiency of PCR in the sample from the dependence of the threshold cycle on the dilution factor for each of the genes | |
US6555327B1 | Monoclonal antibodies against S100 |